UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

Seminars in oncology, 2003-10, Vol.30 (5), p.117-124

2003

Volltextzugriff (PDF)

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

Annals of oncology, 2016-06, Vol.27 (6), p.1029-1034

2016

Volltextzugriff (PDF)

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Journal of clinical oncology, 1999-09, Vol.17 (9), p.2639-2648

1999

Volltextzugriff (PDF)

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

Journal of clinical oncology, 1996-05, Vol.14 (5), p.1718-1729

1996

Volltextzugriff (PDF)

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

British journal of cancer, 2014-09, Vol.111 (6), p.1241-1248

2014

Volltextzugriff (PDF)

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument

Journal of clinical oncology, 1997-03, Vol.15 (3), p.974-986

1997

Volltextzugriff (PDF)

Learning Assumptions for Compositional Verification

Tools and Algorithms for the Construction and Analysis of Systems, p.331-346

Volltextzugriff (PDF)

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

European journal of cancer (1990), 2001-01, Vol.37 Suppl 1, p.S25-29

2001

Volltextzugriff (PDF)

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination

Advances in radiation oncology, 2019-07, Vol.4 (3), p.453-457

2019

Volltextzugriff (PDF)

Pathologic Findings in MRI-Guided Needle Core Biopsies of the Breast in Patients with Newly Diagnosed Breast Cancer

International Journal of Breast Cancer, 2011-01, Vol.2011 (2011), p.183-185

2011

Volltextzugriff (PDF)

Self-reported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: a cross-sectional examination

Breast cancer research and treatment, 2002, Vol.71 (2), p.113-123

2002

Volltextzugriff (PDF)

Flow analysis for verifying properties of concurrent software systems

ACM transactions on software engineering and methodology, 2004-10, Vol.13 (4), p.359-430

2004

Volltextzugriff (PDF)

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Oncology, 2001-01, Vol.61 (Suppl 2), p.37-42

2001

Volltextzugriff (PDF)

Hormone replacement therapy and high S phase in breast cancer

JAMA : the journal of the American Medical Association, 1999-04, Vol.281 (16), p.1528

1999

Volltextzugriff (PDF)

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breast cancer research and treatment, 2021-09, Vol.189 (2), p.377-386

2021

Volltextzugriff (PDF)

Breaking up is hard to do: An evaluation of automated assume-guarantee reasoning

ACM transactions on software engineering and methodology, 2008-04, Vol.17 (2), p.1-52

2008

Volltextzugriff (PDF)

Safety and Efficacy of Palbociclib (CDK4/6 inhibitor) and Radiotherapy in Metastatic Breast Cancer Patients: Initial Results of a Novel Combination

International journal of radiation oncology, biology, physics, 2019-09, Vol.105 (1), p.E2-E2

2019

Volltextzugriff (PDF)

Abstract P2-10-10: Oncotype Dx testing in patients with synchronous unilateral primary breast cancer

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-10-10

2018

Volltextzugriff (PDF)

Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression

Journal of clinical oncology, 2004-03, Vol.22 (6), p.1063-1070

2004

Volltextzugriff (PDF)

Prevalence of Sarcopenia in Women with Metastatic Breast Cancer

Journal of the Academy of Nutrition and Dietetics, 2020-09, Vol.120 (9), p.A29-A29

2020

Volltextzugriff (PDF)

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

Annals of oncology, 2002-08, Vol.13 (8), p.1220-1224

2002

Volltextzugriff (PDF)

Learning to divide and conquer: applying the L algorithm to automate assume-guarantee reasoning

Formal methods in system design, 2008-06, Vol.32 (3), p.175-205

2008

Volltextzugriff (PDF)

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry

JAMA : the journal of the American Medical Association, 2005-10, Vol.294 (15), p.1925

2005

Volltextzugriff (PDF)

Abstract PD8-12: Safety and efficacy of palbociclib and radiotherapy in metastatic breast cancer patients: Initial results of a novel combination

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD8-12-PD8-12

2019

Volltextzugriff (PDF)

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Journal of clinical oncology, 2005-02, Vol.23 (4), p.792-799

2005

Volltextzugriff (PDF)

1 – 25 von 174

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(144)
Mit Volltextzugriff
(145)

Publikationsform

Sprache

Englisch
(174)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument

Learning Assumptions for Compositional Verification

First-line, single-agent Herceptin(trastuzumab) in metastatic breast cancer: a preliminary report

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination

Pathologic Findings in MRI-Guided Needle Core Biopsies of the Breast in Patients with Newly Diagnosed Breast Cancer

Self-reported dietary habits, overall dietary quality and symptomatology of breast cancer survivors: a cross-sectional examination

Flow analysis for verifying properties of concurrent software systems

First-Line Herceptin® Monotherapy in Metastatic Breast Cancer

Hormone replacement therapy and high S phase in breast cancer

Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer

Breaking up is hard to do: An evaluation of automated assume-guarantee reasoning

Safety and Efficacy of Palbociclib (CDK4/6 inhibitor) and Radiotherapy in Metastatic Breast Cancer Patients: Initial Results of a Novel Combination

Abstract P2-10-10: Oncotype Dx testing in patients with synchronous unilateral primary breast cancer

Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression

Prevalence of Sarcopenia in Women with Metastatic Breast Cancer

A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer

Learning to divide and conquer: applying the L algorithm to automate assume-guarantee reasoning

Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry

Abstract PD8-12: Safety and efficacy of palbociclib and radiotherapy in metastatic breast cancer patients: Initial results of a novel combination

Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer

Suchergebnisse filtern